New therapies for immune thrombocytopenic purpura Review uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Dexamethasone
  • Immunologic Factors
  • Purpura, Thrombocytopenic, Idiopathic
  • Rho(D) Immune Globulin
  • Thrombopoietin

abstract

  • Clinical investigation of novel therapies in immune thrombocytopenic purpura is undergoing a revolution that has the potential to change the standard of care. While older therapies are experiencing a rebirth by being given a new spin, newer agents such as thrombopoietins are showing significant promise.

publication date

  • September 2007

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MOH.0b013e3282a4a68b

PubMed ID

  • 17934347

Additional Document Info

start page

  • 427

end page

  • 31

volume

  • 14

number

  • 5